If you have any doubts about whether you should attend RISE UP 2026, read the summary of last year's meeting here. This year's meeting is shaping up to be even more thought provoking and exciting. If ...

At this year's RISE UP Luncheon, we are honoring the storytellers who are bringing a light to the consequence of restrictions on reproductive healthcare. Come and be inspired. Courage is contagious. T...

34K likes, 1,612 comments - rubin_allergy on January 16, 2026: "Why is there a shortage of OB/Gyn physicians? Will robots replace doctors? #womenshealth #obgyn #doctor".

A pioneering study has found that an individualized approach to breast cancer screening that assesses patients’ risk, rather than automatically giving annual mammograms, can lower the chance of more a...

Join us in being a part of the change by reserving a table for our 2nd RISE UP for Breast Cancer and Women’s Health Satellite Luncheon on Thursday, February 19th, 2026, at 12:00pm at the Hotel Nikko i...

We presented the WISDOM trial results this morning at the San Antonio Breast Cancer Symposium. We were thrilled with the incredibly positive reception of the very remarkable results. Dr. Eric Winer, M...

Waiting and seeing is not often the strategy employed when it comes to treating breast cancer, but a new clinical trial by the University of California, San Francisco, researchers are doing just that.

Your browser isn’t supported anymore. Update it to get the best YouTube experience and our latest features. Learn more

One of the things that I love most is being able to sing my patients to sleep. It provides a welcome distraction from the operating room and also it gives people something to focus on other than the s...

I'm extremely grateful to get this award for leadership from Fierce Pharma. Back in 1993 no one had centers that integrated all the aspects of care for women, and women were frustrated at not having...

“This is the future... And I want young people to feel like wow, there’s a hugely important and exciting area of study — and it’s prevention.” WISDOM founder Dr. Laura Esserman sat down with the San ...

When clinical trials are personalized, more people want to be on them. Trials should look more like care, and care should look more like trials. Our systems for care and research need to be the same s...

I was honored to be the 50th Freyer Lecturer at the Sir Peter Freyer Surgical Symposium, talking about the path to personalized medicine and how to think about incorporating these principles into your...

I had a great time talking to the South Australian Breast Cancer Study Group about the I-SPY trial. We talked about the journey of developing a way to individualize care based on response to improve o...

YouTube video by CBS Evening News

I had a great time giving the Florey Lecture at the University of Adelaide last week. It is time for us to think about personalizing treatment. We’ve been on a journey to personalize screening, becau...

Excited to reconnect with Aditya Bardia now that he is on the west coast. We will work on creating better regulatory endpoints for neoadjuvant breast cancer trials!

So fun meeting the residents and faculty at the UCLA Breast Surgery Program! Took the opportunity of giving Grand Rounds to cook up some great collaborations to work on through the awesome UC Athena N...

Excited to be part of this debate! Pragmatic randomized trials rule!

I very much admire ACOG for having the courage to say that the policies that are being pursued are harming the health of women. There are huge disparities in outcomes in terms of breast cancer, matern...

In medicine, we must look for disparities that lead to poor outcomes and work to fix them. Speaking of disparities, we identified that Black women are getting more axillary dissections than white wome...

Response predictive subtype and molecular subtyping matter in all subtypes, including lobular cancer. Women with lobular cancers who have molecularly high-risk disease are shown to benefit from neoadj...

The data from I-SPY show clearly that immune subtyping matters and identifies high-risk breast cancer that’s hormone positive and clearly benefits from immunotherapy. This is the power of a long-stan...

Cancer care requires having a precise set of data that is shared amongst all clinicians and put together in ways that make it easy for clinicians to make decisions, for patients to understand their si...

These are really important issues that will take center stage at the RISE UP for Breast Cancer Meeting, February 19-21. In two sessions, we will cover the use of hormone replacement therapy among wome...

Check out this important paper from Kimberly Badal, PhD—learning how to apply screening in low-resource settings. Lessons learned from the WISDOM breast cancer screening trial can be applied by unders...

The whole WISDOM team is in SF analyzing the results! News soon!

Thrilled to bring together an awesome and fierce group of women from across the investment community on the third anniversary of Dobbs. These women have the courage and capacity to help us redefine th...

Another important publication showing that endocrine therapy is an important treatment for hormone-positive DCIS, showing that it is the most important long-term intervention to reduce the risk of dev...

This paper shows that there is a subset of hormone-positive patients that have an immune signature and respond to chemo and immunotherapy, as well as triple-negative patients that have an immune signa...

Naseem—thank you for your energy and leadership. VC Guerrieres unite!

Check out this AMAZING result.   889 patients with colon cancer were randomized to a structured exercise program versus a health education group about the value of exercise after adjuvant therapy for ...

At the BCC and beyond, we are aspiring to train the future leaders in healthcare, who will drive innovation in healthcare value. This year’s intern reunion, Sparking Innovation, was on Saturday, June ...

Judge rules grant terminations on the basis of DEI and gender identity are discriminatory and illegal

“Funding medical research is about more than just numbers. It's real people,” says Ryan Manriquez, president of the UC Graduate and Professional Council.

“Funding medical research is about more than just numbers. It's real people,” says Ryan Manriquez, president of the UC Graduate and Professional Council.

Federal%20cuts%20by%20the%20Trump%20administration%20can%20have%20negative%20effects%20on%20crucial%20health%20research%20and%20the%20Bay%20Area%20economy.

Objective The aim of this study was to estimate the total national direct cost of breast cancer screening from 2019 to 2022 and project the total national cost and average lifetime cost of screening p...

YouTube video by Florence Comite MD